/
GNTA
$1.80-$0.01 (-0.55%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$42.7M
24M shares
52-week range
$0.55 – $10.00
13% from low
Exchange
NASDAQ
ADRC
Borrow rate
221.69%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-9.20
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $1.8K | $5.1K | $6.0K | $41.7K | $46.5K | $27.0K |
| Gross profit | $0 | −$1.8K | −$5.1K | −$6.0K | −$41.7K | −$46.5K | −$27.0K |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $3.7M | $4.4M | $3.5M | $5.2M | $6.4M | $5.0M | $2.6M |
| Operating income | −$4.6M | −$5.2M | −$5.9M | −$10.8M | −$11.5M | −$10.2M | −$6.3M |
| EBITDA | −$4.6M | −$5.2M | −$5.8M | −$8.3M | −$11.4M | −$9.3M | −$5.9M |
| Net income | −$4.5M | −$5.2M | −$5.8M | −$8.3M | −$11.4M | −$9.3M | −$6.3M |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -0.25 | -0.31 | -0.31 | -0.47 | -0.64 | -0.49 | -0.33 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-0.45 | $-0.45–$-0.45 | 1 |
| 2027 | $0 | $-0.51 | $-0.51–$-0.51 | 1 |
| 2028 | $30M | $-0.18 | $-0.18–$-0.18 | 1 |
| 2029 | $0 | $0.69 | $0.69–$0.69 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Genenta Science S.p.A. American Depositary Shares
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
www.genenta.com- Employees
- 9
- IPO / List date
- Dec 15, 2021
Held by traders on TradeandTell
No one on the platform currently holds GNTA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GNTA as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2011-02-18 | 1-for-50reverse |
| 2009-07-13 | 1-for-50reverse |
Recent trades on TradeandTell
No one on the platform has traded GNTA yet.
